Reset

Advanced Filters
11:00am - 12:15pm EDT - March 18, 2021

Thursday


Objectives:
  • Identify clinical challenges in managing patients with a variety of cancers.
  • Develop an evidence-based approach for the management of these patients.
Thursday
11:00am - 11:45am EDT - March 18, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Describe current surgical management strategies for testicular germ cell tumors.
  • Assess the benefits and limitations of current surgical techniques.
  • Discuss the supportive care needs that arise during surgical management of testicular germ cell tumors.
Thursday
11:00am - 11:45am EDT - March 18, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Discuss the impact cancer and its treatment can have on a survivor’s work status, work performance, and job satisfaction.
  • Review interventions that may enhance return-to-work in cancer survivors.
  • Explain how physical activity and other healthy lifestyle habits may help survivors return to work.
03:30pm - 05:00pm EDT - March 18, 2021

Thursday


Objectives:
  • Discuss the benefits and challenges associated with collecting and utilizing patient-reported outcomes.
  • Apply best practices for incorporating patient-reported outcomes into routine clinical care.
Thursday
03:30pm - 04:15pm EDT - March 18, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Select optimal adjuvant treatment strategies for patients with HER2-positive early-stage breast cancer based on risk of recurrence.
  • Integrate recent advances and available clinical data to optimally sequence HER2-targeted agents in the treatment of HER2-positive metastatic breast cancer.
  • Plan effective therapy for patients with HER2-positive metastatic breast cancer and central nervous system (CNS) metastases.
Thursday


Objectives:
  • Identify the most common hereditary RCC syndromes and their clinical features.
  • Discuss screening and surveillance strategies for patients with a confirmed hereditary RCC syndrome.
  • Review treatment options for patients with a confirmed hereditary RCC syndrome.
Thursday
03:30pm - 04:00pm EDT - March 18, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Recognize the importance of assessing mutational status in GISTs and its treatment and prognostic implications.
  • Review the existing treatment modalities for unresectable and metastatic GISTs and the high rate of drug resistance.
  • Discuss the impact of avapritinib and ripretinib, the two new FDA-approved agents, on the treatment of advanced GISTs.
Thursday


Objectives:
  • Discuss the role of NGS-based techniques in the management of gastroesophageal cancers.
  • Describe the treatment options for second-line and subsequent therapy for patients with metastatic gastroesophageal cancers.
  • Compare and contrast the current evidence for treating metastatic gastric cancer with targeted therapies, and when appropriate, include in the management of these patients.
Thursday
04:15pm - 05:00pm EDT - March 18, 2021
Track: Clinical Updates in Oncology


Objectives:
  • Select optimal neoadjuvant/adjuvant therapy for locally advanced triple negative breast cancer.
  • Recognize key patient factors that influence selection of systemic therapy for metastatic triple negative breast cancer.
  • Optimally manage common toxicities related to new agents used to treat triple negative breast cancer.